Full-Time

Test Automation Engineer

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior

Hyderabad, Telangana, India

Category
QA & Testing
Automation Testing
Quality Assurance
Required Skills
Python
SQL
Java
GraphQL
AWS
JIRA
Jenkins
Databricks
Snowflake
Requirements
  • Hands-on experience executing and analyzing automated test suites
  • 1+ strong experience in Test Automation specialization
  • 3 to 5 years overall experience in QA & Test Automation is expected
  • Strong understanding of test result analysis and defect tracking (JIRA or similar)
  • Basic knowledge of test automation scripting (Python, Java, or similar)
  • Proficient in SQL for data validation
  • Familiarity with ETL/ELT pipelines and data testing concepts
  • Experience with API testing (REST & GraphQL) and schema validation
  • Exposure to cloud data platforms like AWS, Databricks, or Snowflake
  • Understanding of CI/CD tools (e.g., Jenkins, GitLab CI)
  • Good communication and collaboration skills
  • Strong attention to detail and a problem-solving mindset
Responsibilities
  • Execute automated test suites across various layers including data pipelines, APIs, and semantic layers
  • Analyze test automation results, identify failures or inconsistencies, and assist in root cause analysis
  • Generate and share test execution reports with stakeholders, summarizing pass/fail rates and key issues
  • Collaborate with the Senior QA Engineer to triage automation failures and escalate critical issues
  • Assist in test data preparation and test environment setup
  • Perform manual validation as needed to support automation gaps or verify edge cases
  • Log and track defects in JIRA (or similar tools), and follow up on resolutions with relevant teams
  • Help maintain test documentation, including test case updates, runbooks, and regression packs
  • Contribute to test automation scripting, framework maintenance, and CI/CD integration
  • Validate data transformations and flows across platforms like AWS, Databricks, and Snowflake
  • Participate in testing of semantic layers and Graph QL APIs, including schema validation
  • Maintain test documentation and work closely with QA, data engineers, and analysts to ensure data quality
Desired Qualifications
  • Experience with data governance tools such as Apache Atlas, Collibra, or Alation
  • Contributions to internal quality dashboards or data observability systems
  • Awareness of metadata-driven testing approaches and lineage-based validations
  • Experience working with agile Testing methodologies such as Scaled Agile
  • Familiarity with automated testing frameworks like Selenium, JUnit, TestNG, or PyTest

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's approach involves a strong commitment to research and development, allowing them to create new treatments and maintain a pipeline of potential therapies. Unlike many competitors, Amgen emphasizes biologic therapies and reinvests a large portion of its earnings back into R&D. The goal of Amgen is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.